These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 31004601)

  • 41. CD7+ near-tetraploid acute myeloblastic leukemia M2 with double t(8;21)(q22;q22) translocations and Aml1/ETO rearrangements detected by fluorescence in situ hybridization analysis.
    Yamamoto K; Nagata K; Kida A; Tsurukubo Y; Hamaguchi H
    Int J Hematol; 2001 Oct; 74(3):316-21. PubMed ID: 11721969
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic Role of Postinduction Minimal Residual Disease and Myeloid Sarcoma Type Extramedullary Involvement in Pediatric RUNX1-RUNX1T1 (+) Acute Myeloid Leukemia.
    Lee JW; Kim S; Jang PS; Chung NG; Cho B; Im SA; Kim M
    J Pediatr Hematol Oncol; 2020 Apr; 42(3):e132-e139. PubMed ID: 31688618
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group.
    Rücker FG; Agrawal M; Corbacioglu A; Weber D; Kapp-Schwoerer S; Gaidzik VI; Jahn N; Schroeder T; Wattad M; Lübbert M; Koller E; Kindler T; Götze K; Ringhoffer M; Westermann J; Fiedler W; Horst HA; Greil R; Schroers R; Mayer K; Heinicke T; Krauter J; Schlenk RF; Thol F; Heuser M; Ganser A; Bullinger L; Paschka P; Döhner H; Döhner K
    Blood; 2019 Nov; 134(19):1608-1618. PubMed ID: 31554635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An update on the molecular pathogenesis and potential therapeutic targeting of AML with t(8;21)(q22;q22.1);RUNX1-RUNX1T1.
    Al-Harbi S; Aljurf M; Mohty M; Almohareb F; Ahmed SOA
    Blood Adv; 2020 Jan; 4(1):229-238. PubMed ID: 31935293
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge.
    Horny HP; Sotlar K; Sperr WR; Valent P
    J Clin Pathol; 2004 Jun; 57(6):604-8. PubMed ID: 15166264
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1-RUNX1T1 fusion quantification on genomic DNA.
    Duployez N; Nibourel O; Marceau-Renaut A; Willekens C; Helevaut N; Caillault A; Villenet C; Celli-Lebras K; Boissel N; Jourdan E; Dombret H; Figeac M; Preudhomme C; Renneville A
    Am J Hematol; 2014 Jun; 89(6):610-5. PubMed ID: 24616160
    [TBL] [Abstract][Full Text] [Related]  

  • 47. KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis.
    Jawhar M; Döhner K; Kreil S; Schwaab J; Shoumariyeh K; Meggendorfer M; Span LLF; Fuhrmann S; Naumann N; Horny HP; Sotlar K; Kubuschok B; von Bubnoff N; Spiekermann K; Heuser M; Metzgeroth G; Fabarius A; Klein S; Hofmann WK; Kluin-Nelemans HC; Haferlach T; Döhner H; Cross NCP; Sperr WR; Valent P; Reiter A
    Leukemia; 2019 May; 33(5):1124-1134. PubMed ID: 30635631
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute myeloid leukemia with del(X)(p21) and cryptic RUNX1/RUNX1T1 from ins(8;21)(q22;q22q22) revealed by atypical FISH signals.
    Jang JH; Yoo EH; Kim HJ; Kim DH; Jung CW; Kim SH
    Ann Clin Lab Sci; 2010; 40(1):80-4. PubMed ID: 20124335
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical significance of ASXL2 and ZBTB7A mutations and C-terminally truncated RUNX1-RUNX1T1 expression in AML patients with t(8;21) enrolled in the JALSG AML201 study.
    Kawashima N; Akashi A; Nagata Y; Kihara R; Ishikawa Y; Asou N; Ohtake S; Miyawaki S; Sakura T; Ozawa Y; Usui N; Kanamori H; Ito Y; Imai K; Suehiro Y; Kitamura K; Sakaida E; Takeshita A; Suzushima H; Naoe T; Matsumura I; Miyazaki Y; Ogawa S; Kiyoi H;
    Ann Hematol; 2019 Jan; 98(1):83-91. PubMed ID: 30251205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Coexistent t(8;21)(q22;q22) Translocation and 5q Deletion in Acute Myeloid Leukemia.
    Yamamoto K; Yakushijin K; Sanada Y; Kawamoto S; Matsuoka H; Minami H
    J Clin Exp Hematop; 2015; 55(3):181-5. PubMed ID: 26763368
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Myeloid leukemia with t(7;21)(p22;q22) and 5q deletion.
    Panagopoulos I; Gorunova L; Brandal P; Garnes M; Tierens A; Heim S
    Oncol Rep; 2013 Oct; 30(4):1549-52. PubMed ID: 23877199
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of rare reciprocal RUNX1 rearrangements by next-generation sequencing in acute myeloid leukemia.
    Flach J; Shumilov E; Joncourt R; Porret N; Tchinda J; Legros M; Scarpelli I; Hewer E; Novak U; Schoumans J; Bacher U; Pabst T
    Genes Chromosomes Cancer; 2020 Apr; 59(4):268-274. PubMed ID: 31756777
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO-positive acute myeloid leukemia.
    Nagai S; Ichikawa M; Takahashi T; Sato H; Yokota H; Oshima K; Izutsu K; Hangaishi A; Kanda Y; Motokura T; Chiba S; Yatomi Y; Kurokawa M
    Exp Hematol; 2007 Nov; 35(11):1747-52. PubMed ID: 17976525
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute myeloid leukemia with a RUNX1-RUNX1T1 t(1;21;8)(q21;q22;q22) novel variant: a case report and review of the literature.
    Kim H; Moon HW; Hur M; Yun YM; Lee MH
    Acta Haematol; 2011; 125(4):237-41. PubMed ID: 21325813
    [TBL] [Abstract][Full Text] [Related]  

  • 55. t(8;21)(q22;q22) Translocation involving AML1 and ETO in B lymphoblastic leukemia [corrected].
    Wang HY; Tirado CA
    Hum Pathol; 2010 Feb; 41(2):286-92. PubMed ID: 19896694
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/RUNX1-RUNX1T1 chromosomal translocations.
    Micol JB; Duployez N; Boissel N; Petit A; Geffroy S; Nibourel O; Lacombe C; Lapillonne H; Etancelin P; Figeac M; Renneville A; Castaigne S; Leverger G; Ifrah N; Dombret H; Preudhomme C; Abdel-Wahab O; Jourdan E
    Blood; 2014 Aug; 124(9):1445-9. PubMed ID: 24973361
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel RUNX1-C11orf41 fusion gene in a case of acute myeloid leukemia with a t(11;21)(p14;q22).
    Abe A; Katsumi A; Kobayashi M; Okamoto A; Tokuda M; Kanie T; Yamamoto Y; Naoe T; Emi N
    Cancer Genet; 2012 Nov; 205(11):608-11. PubMed ID: 23102734
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Three way translocation in a new variant of t(8;21) acute myeloid leukemia involving Xp22.
    Vundinti BR; Kerketta L; Madkaikar M; Jijina F; Ghosh K
    Indian J Cancer; 2008; 45(1):30-2. PubMed ID: 18453738
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Decoding of exon splicing patterns in the human RUNX1-RUNX1T1 fusion gene.
    Grinev VV; Migas AA; Kirsanava AD; Mishkova OA; Siomava N; Ramanouskaya TV; Vaitsiankova AV; Ilyushonak IM; Nazarov PV; Vallar L; Aleinikova OV
    Int J Biochem Cell Biol; 2015 Nov; 68():48-58. PubMed ID: 26320575
    [TBL] [Abstract][Full Text] [Related]  

  • 60. AML with RUNX1::RUNX1T1 Cooperating two Mutations Relapsed Quickly after Achieving CR.
    XinhongYang ; Wu Y; Yang X; Wu X; Chen Y; Zhang R; Zhang Z
    Clin Lab; 2024 Mar; 70(3):. PubMed ID: 38469780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.